| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,365 |
12,415 |
$1.92M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,933 |
10,266 |
$1.48M |
| 99000 |
|
8,839 |
7,531 |
$328K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
8,688 |
7,544 |
$324K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,205 |
2,203 |
$322K |
| 99442 |
|
1,786 |
1,657 |
$226K |
| 17110 |
|
641 |
564 |
$194K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,572 |
1,572 |
$193K |
| 99441 |
|
1,353 |
1,311 |
$171K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,159 |
1,159 |
$148K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,160 |
1,150 |
$146K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
996 |
969 |
$122K |
| 99050 |
|
8,052 |
7,276 |
$104K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
940 |
685 |
$97K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
393 |
393 |
$51K |
| 99215 |
Prolong outpt/office vis |
383 |
351 |
$49K |
| 99051 |
|
3,735 |
3,445 |
$48K |
| 99188 |
|
723 |
723 |
$40K |
| 87428 |
|
1,222 |
1,127 |
$39K |
| 99443 |
|
296 |
277 |
$37K |
| 99381 |
|
299 |
298 |
$37K |
| 17250 |
|
90 |
84 |
$27K |
| 36416 |
|
628 |
518 |
$19K |
| 90697 |
|
547 |
547 |
$12K |
| 90710 |
|
519 |
519 |
$11K |
| 90677 |
|
422 |
421 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
636 |
432 |
$8K |
| 90670 |
|
325 |
325 |
$6K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
24 |
24 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
43 |
43 |
$5K |
| 90686 |
|
214 |
214 |
$5K |
| 90723 |
|
236 |
236 |
$5K |
| 10060 |
|
17 |
14 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
187 |
181 |
$4K |
| 99383 |
|
26 |
26 |
$3K |
| 90700 |
|
135 |
135 |
$3K |
| 99382 |
|
25 |
25 |
$3K |
| 92587 |
|
42 |
42 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
137 |
133 |
$3K |
| 90696 |
|
119 |
119 |
$3K |
| 90734 |
|
101 |
101 |
$3K |
| 90715 |
|
66 |
66 |
$2K |
| 90381 |
|
21 |
21 |
$2K |
| 90707 |
|
55 |
55 |
$1K |
| 99001 |
|
24 |
24 |
$845.26 |
| 90716 |
|
24 |
24 |
$719.40 |
| 99401 |
|
13 |
13 |
$554.84 |
| 90744 |
|
15 |
15 |
$376.50 |
| 36415 |
Collection of venous blood by venipuncture |
56 |
56 |
$368.05 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
625 |
315 |
$55.48 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
764 |
697 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
45 |
22 |
$0.00 |
| 96127 |
|
39 |
37 |
$0.00 |
| 30210 |
|
63 |
56 |
$0.00 |
| 81000 |
|
13 |
13 |
$0.00 |